Anne- MarieMartinMD

PubMed

• HER-2 gene amplification, HER-2 and epidermal growth factor receptor mRNA and protein expression, and lapatinib efficacy in women with metastatic breast cancer.
  Press, M.F., Finn, R.S., Cameron, D., Di Leo, A., Geyer, C.E., Villalobos, I.E., Santiago, A., Guzman, R., Gasparyan, A., Ma, Y., Danenberg, K., Martin, A.M., Williams...> ;Clin Cancer Res. 2008-12-01
• 35 citations
  Increased AICD generation does not result in increased nuclear translocation or activation of target gene transcription.
  Elaine Waldron, Simone Isbert, Andreas Kern, Sebastian Jaeger, Anne M. Martin, Sébastien S. Hébert, Christian Behl, Sascha Weggen, Bart De Strooper, Claus U. Pietrzik> ;Experimental Cell Research. 2008 Aug 1
• 55 citations
  LRP1 modulates APP trafficking along early compartments of the secretory pathway
  Elaine Waldron, Catherine Heilig, Andrea Schweitzer, Nirupa Nadella, Sebastian Jaeger, Anne M. Martin, Sascha Weggen, Klaudia Brix, Claus U. Pietrzik> ;Neurobiology of Disease. 2008 Aug 1
• 80 citations
  The functional role of the second NPXY motif of the LRP1 beta-chain in tissue-type plasminogen activator-mediated activation of N-methyl-D-aspartate receptors
  Anne M. Martin, Christoph R.W. Kuhlmann, Svenja Trossbach, Sebastian Jaeger, Elaine Waldron, Anton Roebroek, Heiko J. Luhmann, Alexander Laatsch, Sascha Weggen, Volkma...> ;The Journal of Biological Chemistry. 2008 May 2
• Genome-wide DNA copy number predictors of lapatinib sensitivity in tumor-derived cell lines.
  Greshock, J., Cheng, J., Rusnak, D., Martin, A.M., Wooster, R., Gilmer, T., Lee, K., Weber, B.L., Zaks, T.> ;Mol Cancer Ther. 2008 Apr
• Should continuous lateral rotation therapy replace manual turning?
  Martin, A. H.> ;Dimens Crit Care Nurs. 2001 Jan 01
• Lapatinib plus capecitabine in treating HER2-positive advanced breast cancer: efficacy, safety, and biomarker results from Chinese patients.
  Xu, B. H., Jiang, Z. F., Chua, D., Shao, Z. M., Luo, R. C., Wang, X. J., Liu, D. G., Yeo, W., Yu, S. Y., Newstat, B., Preston, A., Martin, A. M., Chi, H. D., Wang, L.> ;Chin J Cancer. 2011 May
• Interleukin-6 -174G-->C polymorphism is associated with improved outcome in high-risk breast cancer.
  DeMichele, A., Martin, A. M., Mick, R., Gor, P., Wray, L., Klein-Cabral, M., Athanasiadis, G., Colligan, T., Stadtmauer, E., Weber, B.> ;Cancer Res. 2003 Nov 15
• Thrombopoietin receptor levels in tumor cell lines and primary tumors.
  Erickson-Miller, C. L., Chadderton, A., Gibbard, A., Kirchner, J., Pillarisetti, K., Baker, K., Pandite, L., El-Hariry, I., Mostafa Kamel, Y., Liu, Y., Martin, A. M., ...> ;J Oncol. 2010
• Cancer cell lines as genetic models of their parent histology: analyses based on array comparative genomic hybridization.
  Greshock, J., Nathanson, K., Martin, A. M., Zhang, L., Coukos, G., Weber, B. L., Zaks, T. Z.> ;Cancer Res. 2007 Apr 15
• Synergistic effects of foretinib with HER-targeted agents in MET and HER1- or HER2-coactivated tumor cells.
  Liu, L., Shi, H., Liu, Y., Anderson, A., Peterson, J., Greger, J., Martin, A. M., Gilmer, T. M.> ;Mol Cancer Ther. 2011 Mar
• Human epidermal growth factor receptor 2 (HER2) extracellular domain levels are associated with progression-free survival in patients with HER2-positive metastatic bre...
  Lipton, A., Leitzel, K., Ali, S. M., Carney, W., Platek, G., Steplewski, K., Westlund, R., Gagnon, R., Martin, A. M., Maltzman, J.> ;Cancer. 2011 Nov 1
• Novel mechanism of lapatinib resistance in HER2-positive breast tumor cells: activation of AXL.
  Liu, L., Greger, J., Shi, H., Liu, Y., Greshock, J., Annan, R., Halsey, W., Sathe, G. M., Martin, A. M., Gilmer, T. M.> ;Cancer Res. 2009 Sep 01
• Join now to see all